marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Checkpoint Therapeutics Income Statement 2011-2024 | CKPT
Annual Income Statement Checkpoint Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
36.4 M | 32.8 M | 13.6 M | 181 M | 63.9 M | 108 M | 90.5 M | 237 M | - | - | - | - | - |
Shares |
18.7 M | 8.84 M | 7.6 M | 55.8 M | 35.3 M | 28.6 M | 22.6 M | 21.5 M | - | - | - | - | - |
Historical Prices |
1.94 | 3.71 | 1.79 | 3.21 | 1.75 | 2.79 | 4.5 | 15 | - | - | - | - | - |
Net Income |
-51.8 M | -62.6 M | -56.7 M | -23.1 M | -24.7 M | -36.4 M | -22.7 M | -22.5 M | -13.9 M | - | - | - | - |
Revenue |
103 K | 192 K | 268 K | 1.07 M | 1.71 M | 3.51 M | 1.72 M | 2.57 M | 590 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 1.07 | - | - | - | - | - | - | - | - | - |
Operating Income |
-52.1 M | -58.3 M | -56.7 M | -23.2 M | -24.8 M | -36.7 M | -22.8 M | -22.2 M | -13.2 M | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | 344 K | 235 K | - | - | - | - |
EBITDA |
-52.1 M | -58.3 M | -56.7 M | -23.2 M | -24.8 M | -36.7 M | -22.7 M | -22.1 M | -13.2 M | - | - | - | - |
Operating Expenses |
52.3 M | 58.5 M | 57 M | 24.3 M | 26.6 M | 40.2 M | 24.5 M | 24.7 M | 13.8 M | - | - | - | - |
General and Administrative Expenses |
8.68 M | 8.7 M | 8.54 M | 7.92 M | 7.23 M | 6.59 M | 5.42 M | 4.47 M | 2.49 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Checkpoint Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
43.2 M | 36.5 M | 27 M | 20 M | 15.7 M | 11.7 M | 9.59 M | 8.86 M | 8.75 M | 8.5 M | 77.6 M | 78.5 M | 75.5 M | 70.3 M | 62.4 M | 56.4 M | 51.8 M | 50.9 M | 47 M | 34.6 M | 32.7 M | 32.2 M | 27.1 M | 29.2 M | 29 M | 24.8 M | 18.5 M | 22.8 M | 22.7 M | 22.1 M | 17.4 M | 21.8 M | 21.7 M | 20.8 M | 16 M | 8.53 M | - | - | 8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-9.72 M | -6.67 M | - | -5.72 M | -16.5 M | -10.5 M | - | -10.6 M | -14.1 M | -16.8 M | - | -11.3 M | -9.14 M | -6.5 M | - | -4.93 M | -4.64 M | -3.28 M | - | -5.21 M | -4.79 M | -5.89 M | -11.6 M | -9.34 M | -6.64 M | -8.76 M | -5.92 M | -5.93 M | -6.45 M | -4.38 M | -8.32 M | -5.13 M | -5.4 M | -3.6 M | -8.05 M | -3.75 M | -475 K | -1.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | 41 K | - | 31 K | 31 K | 35 K | - | 48 K | 18 K | 52 K | - | 29 K | 155 K | 68 K | - | 28 K | 42 K | 972 K | - | 280 K | 1.05 M | 352 K | 3.03 M | 5 K | 127 K | 343 K | 332 K | 349 K | 351 K | 693 K | 498 K | 546 K | 1.25 M | 277 K | 65 K | 25 K | - | 500 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-9.72 M | -6.67 M | - | -7.7 M | -16.2 M | -18.1 M | - | -10.7 M | -14.2 M | -16.9 M | - | -11.3 M | -9.16 M | -6.52 M | - | -4.94 M | -4.67 M | -3.34 M | - | -5.23 M | -4.83 M | -5.93 M | - | -9.39 M | -6.68 M | -8.78 M | - | -5.95 M | -6.47 M | -4.41 M | - | -5.14 M | -5.42 M | -3.27 M | - | -3.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 344 K | - | 70 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-9.72 M | -6.67 M | - | -7.7 M | -16.2 M | -18.1 M | - | -10.7 M | -14.2 M | -16.9 M | - | -11.3 M | -9.16 M | -6.52 M | - | -4.94 M | -4.67 M | -3.34 M | - | -5.23 M | -4.83 M | -5.93 M | - | -9.39 M | -6.68 M | -8.78 M | - | -5.95 M | -6.47 M | -4.41 M | - | -5.14 M | -5.42 M | -3.27 M | - | -3.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
9.72 M | 6.71 M | - | 7.73 M | 16.2 M | 18.1 M | - | 10.7 M | 14.2 M | 16.9 M | - | 11.3 M | 9.31 M | 6.59 M | - | 4.97 M | 4.72 M | 4.31 M | - | 5.51 M | 5.88 M | 6.28 M | 14.9 M | 9.39 M | 6.8 M | 9.13 M | 6.27 M | 6.3 M | 6.82 M | 5.11 M | 8.83 M | 5.68 M | 6.67 M | 3.55 M | 7.52 M | 3.7 M | 475 K | 2.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.36 M | 2.23 M | - | 2.24 M | 2.28 M | 2.29 M | - | 1.85 M | 2.13 M | 2.24 M | - | 1.92 M | 2.11 M | 2.37 M | - | 2.43 M | 1.69 M | 1.68 M | - | 1.62 M | 1.76 M | 1.7 M | - | 1.54 M | 1.35 M | 2.19 M | - | 1.34 M | 1.32 M | 1.4 M | - | 972 K | 1.22 M | 1.18 M | - | 219 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency